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Abstract Although the inositol 1,4,5-triphosphate (IP3)-in-
duced nuclear Ca2+ release has been shown to play key roles
in nuclear functions, the presence of IP3 receptor (IP3R)/Ca2
+
channels in the nucleoplasm has not been found. Recently, the
IP3R/Ca2
+ channels were reported to exist in the nucleoplasmic
reticulum structure, an extension of the nuclear envelope. Here
we investigated the potential existence of the IP3Rs in the nu-
cleoplasm and found the presence of all three IP3R isoforms in
neuroendocrine and non-neuroendocrine cells. The IP3Rs were
widely scattered in the nucleoplasm, localizing in both the het-
erochromatin and euchromatin regions.
, 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Despite the critical roles calcium ions play in controlling
nuclear functions including chromosome replication and tran-
scription control [1], very little information is available re-
garding the Ca2þ control mechanisms in the nucleus. In a
recent study, chromosomes were shown to contain 20^32
mM Ca2þ, and the chromosomal Ca2þ concentration was
shown to £uctuate depending on the chromosome replication
state [2]. This indicates that the nucleus not only stores a large
amount of Ca2þ but also has a high capacity Ca2þ-bu¡ering
ability.
Underscoring the importance of nuclear Ca2þ, inositol
1,4,5-triphosphate (IP3)-mediated nuclear Ca2þ release is
known to be essential in the fusion of nuclear vesicles during
cell division [3]. However, since the report of IP3-induced
Ca2þ release from the nucleus [4], nuclear Ca2þ release has
until recently been attributed to the IP3-induced Ca2þ release
from the nuclear envelope (NE) through the IP3R/Ca2þ chan-
nels that exist in the NE [5^7].
Furthermore, some NE membranes have been shown to
penetrate into the nucleoplasm, appearing as thin channel-
like [8] or reticulum-like [9] structures. This nucleoplasmic
reticulum was reported to contain the IP3 receptor (IP3R)/
Ca2þ channels, enabling the nucleoplasmic reticulum to func-
tion as an IP3-sensitive Ca2þ store [9]. In view of the presence
of IP3Rs in the NE [5^7], the existence of IP3Rs in the nucle-
oplasmic reticulum is not surprising. Moreover, the IP3-in-
duced Ca2þ release from the nucleoplasmic reticulum was
proposed to be directly responsible for the IP3-induced Ca2þ
mobilization in the nucleoplasm [9].
Nevertheless, there is still a question of how IP3 produced
as a result of agonist application causes a robust release of
Ca2þ from the nucleoplasmic reticulum deep in the nucleo-
plasm. The IP3 that opens the IP3R/Ca2þ channels of the
nucleoplasmic reticulum should also open the NE IP3R/
Ca2þ channels ahead of the nucleoplasmic reticulum IP3R/
Ca2þ channels because the nucleoplasmic reticulum is the ex-
tension of the NE into the nucleoplasm [8,9]. Even in the case
where IP3 induces release of Ca2þ from the nucleoplasmic
reticulum, the question whether this calcium is the source of
the robust Ca2þ increases in the nucleoplasm still remains
because the nucleoplasmic reticulum occupies a very limited
area of the total nucleoplasm [8,9].
The possibility of the presence and operation of the IP3-
mediated nuclear Ca2þ control mechanism in the nucleoplasm
has been implied from the ¢ndings that the nucleoplasm con-
tains phosphatidylinositol 4,5-bisphosphate (PIP2) and phos-
pholipase C activity [10^14]. Considering that the presence of
IP3Rs in the nucleoplasm is a prerequisite for the IP3-medi-
ated Ca2þ release mechanism to operate in the nucleoplasm,
we have explored in the present study the possibility of the
existence of IP3Rs in the nucleoplasm and found the wide-
spread presence of all three isoforms of IP3Rs (IP3R-1, -2, and
-3) in the nucleoplasm.
2. Materials and methods
2.1. Antibodies
IP3R peptides speci¢c to the terminal 10^13 amino acids of type 1
(HPPHMNVNPQQPA), type 2 (SNTPHENHHMPPA) and type 3
(FVDVQNCMSR) were synthesized with a carboxy-terminal cysteine
and anti-rabbit polyclonal antibodies were raised. The polyclonal anti-
rabbit antibodies were a⁄nity-puri¢ed on each immobilized peptide
following the procedure described [15], and the speci¢city of each
antibody was con¢rmed [16]. Calreticulin antibody was from Calbio-
chem (USA).
2.2. Immunocytochemical localization of IP3R-1, -2, and -3 in adrenal
chroma⁄n and NIH3T3 cells
For the immunogold electron microscopic (EM) study of chromaf-
¢n cells, tissue samples from bovine adrenal medulla were ¢xed for 2 h
at 4‡C in phosphate-bu¡ered saline (PBS) containing 0.1% glutaral-
dehyde, 4% paraformaldehyde, and 3.5% sucrose. After three washes
in PBS, the tissues were post¢xed with 1% osmium tetroxide on ice for
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2 h, washed three times, and stained en bloc with 0.5% uranyl acetate,
all in PBS. The tissues were then embedded in Epon 812 after dehy-
dration in an ethanol series. Ultrathin sections were collected on
Formvar/carbon-coated nickel grids, which were then £oated on drops
of freshly prepared 3% sodium metaperiodate [17] for 30 min. The
immunogold labeling procedure was modi¢ed from Spector et al. [18]
and the manufacturer’s recommended protocol (British Biocell Inter-
national, UK). After etching and washing, the grids were placed on 50
Wl droplets of solution A (phosphate saline solution, pH 8.2, contain-
ing 4% normal goat serum, 1% bovine serum albumin, 0.1% Tween
20, 0.1% sodium azide) for 30 min. Grids were then incubated for 2 h
at room temperature in a humidi¢ed chamber on 50 Wl droplets of
each IP3R isoform-speci¢c antibody appropriately diluted in solution
B (solution A but with 1% normal goat serum), followed by rinses in
solution B. The grids were reacted with 10 nm gold-conjugated goat
anti-rabbit IgG diluted in solution A. Controls for the speci¢city of
each IP3R isoform-speci¢c immunogold labeling included (1) omitting
the primary antibody, (2) replacing the primary antibody with the
preimmune serum, and (3) adding the primary antibody in the excess
presence of each IP3R isoform-speci¢c peptide that had been used to
raise the antibody. After washes in PBS and deionized water, the grids
were stained with uranyl acetate (7 min) and lead citrate (2 min), and
were viewed with a Zeiss EM912 electron microscope.
For the immunogold EM study of NIH3T3 cells, NIH3T3 cells that
had been grown on culture dishes were rinsed with PBS, followed by
¢xation in PBS containing 0.1% glutaraldehyde, 4% paraformalde-
hyde, and 3.5% sucrose for 1 h at 4‡C. The cells were then scraped
from the culture dish and centrifuged to obtain the cell pellet that was
later embedded in 1% agar in PBS. The cell blocks were then washed
three times in PBS, followed by post¢xation with 1% osmium tetrox-
ide on ice for 2 h. The remaining steps followed the procedure de-
scribed above for the adrenal chroma⁄n cells. For the IP3R-1 and
calreticulin double immunogold labeling experiment, the grids that
had gone through the IP3R-1 labeling step with 10 nm particles
were reacted once more with the calreticulin antibody labeled with
15 nm gold particles.
3. Results
3.1. IP3R-1, -2, and -3 in the nucleus of adrenal chroma⁄n
cells
To determine the presence of IP3Rs in the nucleus, the
presence of each isoform of IP3R in the subcellular organelles
of bovine adrenal medullary chroma⁄n cells was examined
using immunogold EM. As shown in Fig. 1A, the IP3R-1-
labeling gold particles were found in the endoplasmic reticu-
lum (ER), secretory granules, and the nucleus, but not in
mitochondria. Presence of the IP3R in the ER [19,20], the
nucleus [5^7], and secretory granules [15,21^23] has been re-
ported before. In secretory granules where the membrane
structures are visible, the IP3R-1-labeling gold particles
were localized primarily in the membrane regions. How-
ever, in the nucleus the IP3R-1-labeling gold particles were
localized not only in the membrane region but also in the
nucleoplasm.
The localization of IP3R-2 was similar to that of IP3R-1. As
shown in Fig. 1B, the IP3R-2-labeling gold particles were
found in the ER, secretory granules, and the nucleus, but
not in mitochondria. Again, in secretory granules the IP3R-
2-labeling gold particles were localized primarily in the mem-
brane regions. However, in the nucleus the IP3R-2-labeling
gold particles were localized not only in the membrane region
but in the nucleoplasm as well. Likewise, the IP3R-3-labeling
gold particles were also localized in the ER, secretory gran-
ules, and the nucleus, but not in mitochondria (Fig. 1C). In
secretory granules the IP3R-3-labeling gold particles were lo-
calized primarily in the membrane regions, but in the nucleus
they were found in both the membrane and the nucleoplasm.
Identical experiments were carried out either in the presence
of an excess amount of each IP3R isoform-speci¢c peptide
that had been used to raise the cognate antibody or in the
absence of the primary antibody, or with the preimmune se-
rum in place of the primary antibody (Fig. 1D).
Consistent with the absence of IP3Rs in mitochondria, vir-
tually no IP3R-labeling gold particles were found in mito-
chondria except the particles shown as a result of non-speci¢c
binding (see Table 1). Nevertheless, despite our present stain-
ing method that could have revealed any reticulum-like or
channel-like structures, we did not notice any nucleoplasmic
reticulum-like or nuclear channel-like structures [8,9] in these
pictures.
To compare the relative abundance of the IP3R isoforms in
each organelle, we counted IP3R isoform-labeling gold par-
ticles in each organelle from 15 di¡erent images that had been
prepared from ¢ve to seven di¡erent tissue preparations. As
shown in Table 1, 23.1 IP3R-1-labeling gold particles/Wm2 of
the ER were found while the number of IP3R-1-labeling gold
particles/Wm2 of the nucleus was 24.9. Even taking 3.2 gold
particles found per Wm2 of mitochondria, which is the level of
non-speci¢c binding, into consideration, 24.9 IP3R-1-labeling
gold particles found per Wm2 of the nucleus clearly demon-
strates the presence of IP3R-1 in the nucleus. Di¡erentiation
of the IP3R-1-labeling gold particles between the NE and the
nucleoplasm indicated that the IP3R-1 concentration in the
NE is higher than that in either the nucleoplasm or the ER
(Table 1).
In an identical experiment, the number of IP3R-2-labeling
gold particles found per Wm2 of the nucleus was 29.8 while
that of the ER was 26.1, and the number for mitochondria
was 1.8. Similar to the results shown with the IP3R-1, the
Table 1
Distribution of the IP3R-1, -2, and -3-labeled gold particles in bovine adrenal medullary chroma⁄n cell
IP3R-1 IP3R-2 IP3R-3
Number of gold
particlesa/area viewed
(Wm2)
Gold
particles/Wm2
Number of gold
particlesb/area viewed
(Wm2)
Gold
particles/Wm2
Number of gold
particlesc/area viewed
(Wm2)
Gold
particles/Wm2
Secretory granule 555/6.05 91.7 519/5.71 90.9 534/5.93 90.1
Nucleus 455/18.25 24.9 505/16.96 29.8 573/21.15 27.1
NE 35/0.97 36.08 39/0.90 43.38 43/1.12 38.36
Nucleoplasm 420/17.28 24.30 466/16.06 29.01 530/20.03 26.46
ER 207/8.96 23.1 185/7.08 26.1 214/8.41 25.5
Mitochondria 11/3.40 3.2 5/2.83 1.8 6/2.87 2.1
aFifteen images from six di¡erent tissue preparations were used.
bFifteen images from ¢ve di¡erent tissue preparations were used.
cFifteen images from seven di¡erent tissue preparations were used.
FEBS 27867 20-11-03
Y.H. Huh, S.H. Yoo/FEBS Letters 555 (2003) 411^418412
Fig. 1. Immunogold EM showing the localization of the IP3R-1, -2, and -3 in bovine adrenal medullary chroma⁄n cells. Bovine adrenal medullary chroma⁄n cells were immunolabeled for the
IP3R-1 (A), IP3R-2 (B), and IP3R-3 (C) (10 nm gold) with a⁄nity-puri¢ed isoform-speci¢c IP3R antibodies. Identical experiments were carried out either in the presence of an excess amount of
each IP3R isoform-speci¢c peptide or in the absence of the primary antibody, or with the preimmune serum in place of the primary antibody (D). The IP3R isoform-labeling gold particles are lo-
calized in the endoplasmic reticulum (er) and the nucleus (Nu), but not in mitochondria (M). The IP3R isoform-labeling gold particles are localized not only in the membrane region but also in
the nucleoplasmic region of the nucleus. Bar = 200 nm.
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Fig. 2. Immunogold EM showing the localization of the IP3R-1, -2, and -3 in NIH3T3 cells. Non-neuroendocrine NIH3T3 cells were immunolabeled for the IP3R-1 (A), IP3R-2 (B), and IP3R-3
(C) (10 nm gold) with a⁄nity-puri¢ed isoform-speci¢c antibodies. Identical experiments were carried out either in the presence of an excess amount of each IP3R isoform-speci¢c peptide or in
the absence of the primary antibody, or with the preimmune serum in place of the primary antibody (D). The IP3R isoform-labeling gold particles are localized in the ER and the nucleus (Nu),
but not in mitochondria (M). The IP3R isoform-labeling gold particles (indicated by arrows) are localized not only in the membrane region but also in the nucleoplasmic region of the nucleus.
Bar= 200 nm.
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nuclear membrane had a higher concentration of IP3R-2 than
either the nucleoplasm or the ER. Further, the number of
IP3R-3-labeling gold particles found per Wm2 of the nucleus
was 27.1 while those of the ER and mitochondria were 25.5
and 2.1, respectively. Again, the IP3R-3 concentration in the
NE was higher than that of either the nucleoplasm or the ER.
3.2. IP3R-1, -2, and -3 in the nucleus of NIH3T3 cells
The presence of IP3Rs was also studied using non-neuro-
endocrine NIH3T3 cells. IP3R-1-labeling gold particles were
found in the ER and the nucleus, but not in mitochondria
(Fig. 2A). Similar to the results shown with the neuroendo-
crine chroma⁄n cells (Fig. 1A), the IP3R-1-labeling gold par-
ticles were not restricted to the membrane region of the nu-
cleus, but they were localized in the nucleoplasm as well. The
IP3R-1-labeling gold particles in the nucleus were widely lo-
calized in both the heterochromatin and euchromatin regions.
Likewise, the IP3R-2-labeling gold particles were found in
the ER and the nucleus, but not in mitochondria (Fig. 2B).
The IP3R-2-labeling gold particles were not restricted to the
membrane region of the nucleus, but were localized in the
nucleoplasm as well. Similarly, the IP3R-3-labeling gold par-
ticles were found in the ER and the nucleus, but not in mi-
tochondria (Fig. 2C). Again, the IP3R-3-labeling gold par-
ticles were widely localized in the nucleus, including both
the heterochromatin and euchromatin regions. Consistent
with the absence of IP3Rs in mitochondria, virtually no
IP3R-labeling gold particles were found in mitochondria of
non-neuroendocrine NIH3T3 cells except the particles shown
as a result of non-speci¢c binding (see Table 2). Identical
experiments were carried out either in the presence of an ex-
cess amount of each IP3R isoform-speci¢c peptide that had
been used to raise the cognate antibody or in the absence of
the primary antibody, or with the preimmune serum in place
of the primary antibody (Fig. 2D).
To compare the relative abundance of the IP3R isoforms in
each organelle, we counted IP3R isoform-labeling gold par-
ticles in each organelle from 12^15 di¡erent images prepared
from seven or eight di¡erent tissue preparations. As shown in
Table 2, 7.5 IP3R-1-labeling gold particles/Wm2 of the ER
were found while the number of IP3R-1-labeling gold par-
ticles/Wm2 of the nucleus was 4.5. The number of IP3R-1-la-
beling gold particles found per Wm2 of mitochondria was 0.7,
showing the level of non-speci¢c binding in this experiment.
Hence, 4.5 IP3R-1-labeling gold particles found per Wm2 of
the nucleus clearly demonstrate the presence of IP3R-1 in the
nucleus of NIH3T3 cells, as was the case with adrenal chro-
ma⁄n cells. Di¡erentiation of the IP3R-1-labeling gold par-
ticles between the NE and the nucleoplasm indicated that the
IP3R-1 concentration in the NE is higher than that in either
the nucleoplasm or the ER (Table 2).
Further, the number of IP3R-2-labeling gold particles found
per Wm2 of the nucleus was 6.2 while that of the ER was 10.4.
Unlike adrenal chroma⁄n cells, which appeared to have
slightly higher concentrations of IP3Rs in the nucleus than
in the ER, the concentration of IP3R-2 in NIH3T3 cells was
signi¢cantly higher in the ER than in the nucleus. However,
the IP3R-2 concentration in the NE is higher than that in the
ER.
In an identical experiment, the number of IP3R-3-labeling
gold particles the nucleus was 3.8 while that of the ER was
5.8. Similar to the IP3R-2, the concentration of IP3R-3 was
signi¢cantly higher in the ER than in the nucleus. The number
of each IP3R isoform-labeling gold particles found per Wm2 of
mitochondria was 0.5^0.7 (Table 2), indicating the level of
non-speci¢c binding in the NIH3T3 cells. Nevertheless, similar
to the results shown with the IP3R-1 and -2, the IP3R-3 con-
centration in the NE is higher than that in the ER. Again,
nucleoplasmic reticulum-like structures were not observed in
the NIH3T3 cells examined.
To validate the speci¢city of the IP3R antibodies, the total
Table 2
Distribution of the IP3R-1, -2, and -3-labeled gold particles in NIH3T3 cell
IP3R-1 IP3R-2 IP3R-3
Number of gold particlesa/
area viewed (Wm2)
Gold
particles/Wm2
Number of gold particlesb/
area viewed (Wm2)
Gold
particles/Wm2
Number of gold particlesc/
area viewed (Wm2)
Gold
particles/Wm2
Nucleus 105/23.49 4.5 124/20.16 6.2 64/17.07 3.8
NE 11/1.24 8.83 13/1.07 12.15 7/0.90 7.74
Nucleoplasm 94/22.24 4.23 111/19.09 5.81 57/16.17 3.53
ER 76/10.19 7.5 65/6.23 10.4 37/6.37 5.8
Mitochondria 6/8.16 0.7 4/5.46 0.7 3/5.59 0.5
aFifteen images from eight di¡erent tissue preparations were used.
bThirteen images from seven di¡erent tissue preparations were used.
cTwelve images from seven di¡erent tissue preparations were used.
Fig. 3. Immunoblot of the secretory granule integral membrane pro-
teins and NIH3T3 protein extracts with each type-speci¢c IP3R
antibody. Secretory granule integral membrane proteins from bovine
adrenal medullary chroma⁄n cells (m.p.) and the total protein ex-
tracts from NIH3T3 cells (NIH3T3) were separated on a 7% SDS-
polyacrylamide gel. 10 Wg of each proteins was visualized with Coo-
massie blue staining (A) while 50 Wg of granule membrane proteins
and 100 Wg of NIH3T3 proteins were probed with type-speci¢c
IP3R (IP3R-1, -2, and -3) antibodies used in the immunogold cyto-
chemical studies (B). A 260^280 kDa membrane protein speci¢cally
reacted with each IP3R antibody.
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protein extracts of NIH3T3 cells were separated on an sodium
dodecyl sulfate (SDS)-polyacrylamide gel and the presence of
each IP3R isoform was examined by immunoblot analysis
using each IP3R-speci¢c antibody. As shown in Fig. 3, each
IP3R isoform-speci¢c antibody reacted with a protein of
V270 kDa in the total NIH3T3 cell extracts. The same anti-
body also reacted with V270 kDa proteins of the membrane
proteins of bovine chroma⁄n granules, con¢rming not only
the presence of the IP3R isoforms in the NIH3T3 cells but
also the speci¢city of each IP3R isoform-speci¢c antibody. A
few smaller bands appear to be fragmented IP3Rs.
To further con¢rm the speci¢city of the IP3R-labeling gold
particles, presence of calreticulin, an ER marker protein [24],
in NIH3T3 cells was also tested. As shown in Fig. 4A, calre-
ticulin-labeling gold particles were present in the ER and the
NE, but not in the nucleoplasm. Further, in the IP3R and
calreticulin double labeling immunogold experiment, the
IP3R-1-labeling gold particles were localized in the ER, NE
and the nucleoplasm, whereas the calreticulin-labeling gold
particles were localized in the ER and the NE, but not in
the nucleoplasm (Fig. 4B). To compare the relative abundance
of calreticulin in each organelle, we counted calreticulin-label-
ing gold particles in each organelle from 15 di¡erent images
that had been prepared from ¢ve di¡erent tissue preparations.
The number of calreticulin-labeling gold particles localized per
Wm2 of each organelle was 10.1 for the ER, 2.8 for the nu-
cleus, and 0.51 for mitochondria. When the calreticulin-label-
ing gold particles were di¡erentiated between the NE and the
Fig. 4. Immunogold EM showing the localization of calreticulin in NIH3T3 cells. A: NIH3T3 cells were immunolabeled for calreticulin (10 nm
gold) with the a⁄nity-puri¢ed calreticulin antibody. The calreticulin-labeling gold particles (indicated by arrows) are localized in the ER and
the NE, but not in mitochondria (M). Bar= 200 nm. B: NIH3T3 cells were double immunolabeled for calreticulin (15 nm gold) and the IP3R-
1 (10 nm gold). The calreticulin-labeling gold particles (indicated by large arrowheads) are localized in the ER and the NE while the IP3R-1-la-
beling gold particles (indicated by arrows) are localized in the ER, NE and the nucleoplasm, but not in mitochondria (M). Bar= 200 nm.
FEBS 27867 20-11-03
Y.H. Huh, S.H. Yoo/FEBS Letters 555 (2003) 411^418416
nucleoplasm, there were 19.0 gold particles/Wm2 of the NE
and 0.79 gold particles/Wm2 of the nucleoplasm. The number
of gold particles localized per Wm2 of the nucleoplasm was
slightly higher than that of mitochondria, the organelle
known not to contain calreticulin. Hence, these results clearly
indicate the presence of calreticulin in the ER and the NE as
expected, but suggest the absence of calreticulin in the nucle-
oplasm.
4. Discussion
Despite the known presence of the IP3Rs in the NE [5^7],
the present results do not show a preferential localization of
the IP3Rs in the membrane regions of the nucleus (Figs. 1 and
2). In contrast to the notion that the IP3Rs are limited to the
membrane regions of the NE, the EM pictures clearly show
that the IP3Rs are not restricted to the membrane area but are
distributed throughout the nucleoplasm. The widespread pres-
ence of the IP3Rs in the nucleus not only indicates that the
localization of the IP3Rs cannot be limited to any channel-like
[8] or NE reticulum-like [9] structures that have been shown to
occupy only a very limited area in the nucleoplasm, but it
underscores the presence of IP3Rs in the nucleoplasm far be-
yond any NE extensions that may have penetrated into the
nucleoplasm. Moreover, all three isoforms of the IP3R were
widely localized throughout the nucleus, including both the
heterochromatin and the euchromatin regions of both neuro-
endocrine adrenal chroma⁄n cells and non-neuroendocrine
NIH3T3 cells, thus clearly demonstrating the presence of all
three IP3R isoforms in the nucleoplasm.
Although it had previously been reported that some of the
NE membranes can penetrate into the nucleoplasm [8] and
IP3Rs are found in the NE extensions [25], we did not notice
any invaginated NE membranes in the present study. Since
our present staining method [17] should have revealed any NE
extensions in the nucleoplasm, the present results indicate the
absence of such structures in the pictures viewed. Further, the
IP3Rs were found to be widely scattered in the nucleus (Figs.
1 and 2), not limited to any local areas. Hence the IP3Rs that
had been shown to localize in the nucleoplasm cannot be the
ones contributed by the NE membranes that may have pene-
trated into the nucleoplasm.
In neuroendocrine adrenal chroma⁄n cells, the number of
IP3R isoform-labeling gold particles per Wm2 of the nucleus
was higher than that of the ER in all three IP3R isoforms
(Table 1). However, this was not the case in non-neuroendo-
crine NIH3T3 cells where the number of IP3R isoform-label-
ing gold particles per Wm2 of the nucleus was signi¢cantly
lower than that of the ER in all three IP3R isoforms (Table
2). Though the reason for this di¡erence is not apparent, the
higher concentrations of the IP3Rs in the nucleus of neuro-
endocrine cells than those in the ER might be due to more
active nuclear activities, including transcription of many se-
cretion-related genes, in secretory cells compared to non-se-
cretory cells. Since dynamic nuclear activities cannot occur
without an active control of nuclear Ca2þ concentrations, it
may be a natural consequence that neuroendocrine cells have
relatively higher concentrations of the IP3Rs in the nucleus
than those in the ER.
Consistent with the present results, the nucleus is known to
contain a phosphoinositide signaling system of its own, in-
cluding molecules such as PIP2, phospholipase C, IP3, and
diacylglycerol (DAG) [10^14]. The existence of these mole-
cules and the phosphoinositide signaling system indicates in
nucleo production of the signaling molecules IP3 and DAG,
which suggests the presence and operation of signaling sys-
tems involving these molecules in the nucleus. Further, nu-
clear IP3 was shown to release Ca2þ in nucleo through the
IP3R/Ca2þ channels, thereby stimulating the fusion of nuclear
vesicles in NE assembly [3]. Blocking of Ca2þ release through
the IP3R/Ca2þ channels also inhibited the fusion of nuclear
vesicles [3], underscoring the importance of the IP3-induced
Ca2þ release in nuclear processes. In this respect, the present
results provide the molecular basis for the IP3-induced Ca2þ
mobilization in the nucleoplasm.
Moreover, despite the demonstrated presence of all three
isoforms of IP3Rs in the nucleoplasm, the question of where
the calcium that can be released through the IP3R/Ca2þ chan-
nels is stored in the nucleoplasm still remains. In this regard,
the ¢nding that a high capacity, low a⁄nity Ca2þ storage
protein chromogranin B is present in the nucleus of adrenal
chroma⁄n cells in 20^40 WM [26] appears to be of direct
relevance. Chromogranin B was originally found in secretory
granules of neuroendocrine cells, and binds 93 mol Ca2þ/mol
with a Kd of 1.5 mM [27]. From the nuclear concentration
and the high capacity Ca2þ binding property, chromogranin B
is expected to bind a millimolar range of Ca2þ in the nucleus,
an amount su⁄cient to control a wide range of nuclear Ca2þ
concentrations. Nevertheless, neither chromogranin B nor
other Ca2þ storage proteins have been identi¢ed in non-neu-
roendocrine cells so far, although it is highly probable that
other functionally equivalent Ca2þ binding proteins play sim-
ilar roles.
Deducing from the fact that the IP3R interacts with the
Ca2þ storage protein chromogranin B [28], it is highly plau-
sible that the nuclear IP3R/Ca2þ channels and Ca2þ storage
proteins form a complex to store and release nuclear calcium
in response to IP3. Hence, we hypothesize that this complex
may consist of the IP3R/Ca2þ channel, Ca2þ storage protein,
and phospholipids, thus forming a proteolipid Ca2þ store
complex in a small vesicular structure. In this respect, the
released nuclear Ca2þ may also be sequestered by this proteo-
lipid complex structure, without invoking the need to be
pumped out or be removed through the nuclear pore complex.
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